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Sanchis-Gomar et al. (2009) performed an interesting
experiment on rats, who had received 500 IU of
rHuEPO-alpha three times a week for 2 weeks. These
rats were then divided into two groups: one group was
exposed intermittently to hypoxia (equivalent altitude of
4,000 m, 12 h per day), the other was not. The rats of the
former group had variations of haematological parame-
ters that are coherent with the concept of altitude accli-
matization. This includes, of course, an increase in
endogenous EPO, so that the erythropoietic stimulation
index was altered. So, the authors conclude, intermittent
hypoxic treatment after rHuEPO-alpha administration
can signiWcantly modify the main haematological
parameters tested by the anti-doping authorities. Conse-
quently, Lippi and Franchini argue in their letter that
intermittent hypoxic training should be banned as a dop-
ing procedure. They seem to overlook the fact that rats
were exposed to an equivalent altitude of 4,000 m,
which is not exactly the altitude were athletes use to go,
but this is not a main point: some athletes could well
spend 12 h per day (over night, for instance) in a hypo-
baric chambers at that altitude.
The main point, since we deal with doping, is the fol-
lowing. According to the World Anti-Doping Code (avail-
able at http://www.wada-ama.org) of the World Anti-
Doping Agency (WADA), a substance or a method is
recognised as doping when it meets, or it is a demonstrated
masking agent of a substance that meets, at least two of
these conditions: (1) it improves performance, (2) it carries
along health risks, (3) it is contrary to what the Interna-
tional Olympic Committee calls “the spirit of sport”. Inter-
mittent hypoxia exposure does not improve performance
per se, is not harmful to health, is not contrary to the spirit
of sport more than altitude acclimatization. So the argu-
ment of Luzzi and Franchini must rely on the concept that
intermittent hypoxia is a masking agent (of rhEPO) of
exogenous EPO administration at anti-doping control. But
is it really a masking agent? Exogenous EPO can be identi-
Wed directly in urine and in blood with electrophoresis,
since the electric charge of the rhEpo molecule is less neg-
ative than that of endogenous Epo (Wide et al. 1995). The
method underwent extensive validation, has been Wnely
tuned, is highly reliable nowadays, and has been formally
recognised by WADA in 2003. Intermittent hypoxia expo-
sure does not conceal rhEPO from detection by electropho-
resis. Thus, it cannot be considered, to my mind, a masking
agent. In conclusion, none of the conditions established by
WADA for the inclusion of a substance or a method in the
doping list is fulWlled by intermittent hypoxia exposure. So,
I kindly disagree with the proposal by Luzzi and Franchini
of banning intermittent hypoxia exposure as a doping
procedure.
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